Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Pushes Faster Post-Approval Study Starts In Drug-Eluting Stent Guidance

Mar 31 2008

Related Content

Taxus “Peri-approval” Trial Offers Postmarket Study Model – Zuckerman

Jul 12 2004

Industry Presents Wish List For DES Guidance At CRT Conference

Feb 18 2008

Off-Label Drug-Eluting Stent Data Weak; Label Should Be Revised – Panel

Dec 11 2006

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window